Adults with Down Syndrome (DS) have a substantially increased risk for Alzheimer’s disease (AD) due to the triplicated amyloid-precursor-protein gene on chromosome 21, resulting in amyloid and tau accumulation. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.